The End of the Single Narrative: Fudan Micro's Surge, CK Infra's Cash-Out and the Fractured Hong Kong Market of 2026Global Report·20 hours ago01038-0.80%01854+0.79%
Investors Signal Shift in Hong Kong Equities as Capital Rotates Toward Yield and Advanced ManufacturingGlobal Report·1 day ago, 04:18 AM02356-0.40%03952+15.38%
Cosmax Biotech rises 8% on NMPA collagen approvalHK Stock Market Update·2 days ago, 12:30 AM02367+0.59%
Giant Biologic rises 8% on new consumer strength, NMPA approvalHK Stock Market Update·2 days ago, 10:50 PM02367+0.59%
HKEX Sector Rotation: Mobility, Biotech, and Consumer Staples Navigate Strategic Shifts in 2026Global Report·Jul 21 at 04:13 AM02643+0.81%01780+3.24%
Giant Biogene Holding Co. Ltd. (2367) Receives a Hold from JefferiesTip Ranks·Jul 20 at 09:25 AM02367+0.59%
Broad ETFs Draw Billions as Legacy Retailers Face RestructuringGlobal Report·Jul 18 at 04:13 AM02367+0.59%012550.00%
The Dark Matter of Hong Kong's Market: Why Uncategorized Stocks Tell the Real StoryGlobal Report·Jul 3 at 03:32 AM02688+1.46%02367+0.59%
Bank of America Securities Sticks to Its Buy Rating for Giant Biogene Holding Co. Ltd. (2367)Tip Ranks·Jun 23 at 07:34 PM02367+0.59%
Huatai Securities Reaffirms Their Buy Rating on Giant Biogene Holding Co. Ltd. (2367)Tip Ranks·Jun 19 at 12:07 AM02367+0.59%
Giant Biogene Holding Co. Ltd. (2367) Receives a Buy from Orient SecuritiesTip Ranks·Jun 19 at 12:06 AM02367+0.59%
UBS Sticks to Its Hold Rating for Giant Biogene Holding Co. Ltd. (2367)Tip Ranks·Jun 19 at 12:05 AM02367+0.59%
Citi Sticks to Their Buy Rating for Giant Biogene Holding Co. Ltd. (2367)Tip Ranks·Jun 18 at 07:24 PM02367+0.59%
CICC Cuts GIANT BIOGENE TP to HKD40, Sees Bottom-fishing OpportunityAASTOCKS News·Jun 18 at 03:10 AM02367+0.59%
